Vaccines in development for the primary prevention of Clostridium difficile infection

被引：5
|
作者：
Legenza, Laurel M. [1 ]
Barnett, Susanne G. [1 ]
Rose, Warren E. [1 ]
机构：
[1] Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA
来源：
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION | 2017年 / 57卷 / 04期
关键词：
EPIDEMIOLOGY; GUIDELINES; BURDEN; RISK;
D O I：
10.1016/j.japh.2017.06.007
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：547 / 549
页数：3
相关论文
共 50 条
  • [21] Breakthroughs in the treatment and prevention of Clostridium difficile infection
    Larry K. Kociolek
    Dale N. Gerding
    Nature Reviews Gastroenterology & Hepatology, 2016, 13 : 150 - 160
  • [22] Increase in Incidence of Clostridium Difficile infection in aged models and the need for novel vaccines for the prevention of disease
    Kutzler, Michele A.
    Baliban, Scott M.
    Bernui, Mariana
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [23] Prevention of Clostridium difficile infection in rural hospitals
    Haun, Nicholas
    Hofer, Adam
    Greene, M. Todd
    Borlaug, Gwen
    Pritchett, Jenny
    Scallon, Tina
    Safdar, Nasia
    AMERICAN JOURNAL OF INFECTION CONTROL, 2014, 42 (03) : 311 - 315
  • [24] Detection, Treatment, and Prevention of Clostridium difficile Infection
    McCollum, David L.
    Rodriguez, J. Martin
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (06) : 581 - 592
  • [25] Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
    Wilcox, M. H.
    Gerding, D. N.
    Poxton, I. R.
    Kelly, C.
    Nathan, R.
    Birch, T.
    Cornely, O. A.
    Rahav, G.
    Bouza, E.
    Lee, C.
    Jenkin, G.
    Jensen, W.
    Kim, Y. -S.
    Yoshida, J.
    Gabryelski, L.
    Pedley, A.
    Eves, K.
    Tipping, R.
    Guris, D.
    Kartsonis, N.
    Dorr, M. -B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (04): : 305 - 317
  • [26] Novel Chimeric Protein Vaccines Against Clostridium difficile Infection
    Wang, Shaohui
    Wang, Yuanguo
    Cai, Ying
    Kelly, Ciaran P.
    Sun, Xingmin
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [27] Crossing the quality chasm for Clostridium difficile infection prevention
    Safdar, Nasia
    Perencevich, Eli
    BMJ QUALITY & SAFETY, 2015, 24 (07) : 409 - 411
  • [28] Prevention of Clostridium difficile Infection in Critically Ill Adults
    Leedahl, David D.
    Personett, Heather A.
    Nagpal, Avish
    Barreto, Erin F.
    PHARMACOTHERAPY, 2019, 39 (03): : 399 - 407
  • [29] Clostridium Difficile Infection Prevention, Treatment, and Surgical Management
    Luciano, Jason A.
    Zuckerbraun, Brian S.
    SURGICAL CLINICS OF NORTH AMERICA, 2014, 94 (06) : 1335 - +
  • [30] Bezlotoxumab (Zinplava) for Prevention of Recurrent Clostridium difficile Infection
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1517): : 49 - 50
12345